Electromagnetic Navigation Versus CT Guidance for Locating Lung Nodules
Compares electromagnetic navigation with CT guidance for locating lung nodules in adults.
Key facts
- Who runs it
- Shanghai Pulmonary Hospital, Shanghai, China
- Where
- Shanghai, ChinaSee the site
- Trial code
- Registry title
- Application of Electromagnetic Navigation System in Pulmonary Nodule Localization
- Status
- Not yet recruiting
- People taking part
- 400 people, planned
- Started
- May 2026
- Expected to end
- Apr 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Electromagnetic Navigation-Guided Percutaneous Localization of Pulmonary Nodules
- CT-Guided Percutaneous Localization of Pulmonary Nodules
- Record updated
- 19 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with one small lung nodule who are scheduled to have the nodule marked before surgery. It compares two ways of marking it.
- Age
- 18 to 80 years
- Sex
- All sexes can join.
- Disease stage
- One single lung nodule, at most 2 cm (0.8 in) across at its widest on chest CT. ECOG performance status 0-2.
- Earlier treatment
- No earlier chest surgery or chest infection that caused scarring (adhesions) in the chest.
Main reasons for not taking part
- Cannot have video-assisted thoracoscopic surgery
- Center of the nodule is less than 3 cm (1.2 in) from the top of the diaphragm
- Earlier chest surgery or pleural infection that caused chest adhesions
- Doctor judges that marking the nodule before surgery is not possible
- Cannot complete follow-up or poor compliance
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Age 18-80 years, regardless of gender
- Solitary single nodule, scheduled for lung nodule puncture and localization
- Chest CT (lung window mode) showing a maximum nodule diameter ≤ 2 cm
- Eastern Cooperative Oncology Group (ECOG) performance status score 0-2
- Voluntary participation, with signed informed consent
Who cannot take part
- Not suitable for video-assisted thoracoscopic surgery
- History of thoracic adhesion due to previous thoracotomy or pleural infection
- The distance between the center of the lesion and the dome of the diaphragm is < 3 cm
- Patients judged by the investigator to be unsuitable for preoperative transthoracic or transbronchial localization
- Inability to complete follow-up or poor compliance
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Where in China
- Shanghai Pulmonary HospitalShanghai, ChinaContact: Haifeng WangNo longer taking part
About the trial
What the trial wants to find out
This study aims to design and conduct a multicenter, prospective, randomized controlled post-market clinical trial to validate the clinical efficacy of high-precision electromagnetic navigation technology.
The 2 groups in the trial
- Electromagnetic Navigation Localization GroupTreatment being tested
Treatment: Electromagnetic Navigation-Guided Percutaneous Localization of Pulmonary Nodules
- CT-Guided Localization GroupExisting treatment, for comparison
Treatment: CT-Guided Percutaneous Localization of Pulmonary Nodules
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Electromagnetic Navigation-Guided Versus CT-Guided Localization of Pulmonary Nodules: A Multicenter, Prospective, Randomized Controlled Trial
- Plain-language title
- Electromagnetic Navigation Versus CT Guidance for Locating Lung NodulesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Fit questions
- Built from NCT07595120, who can take part
- Record updated
- 19 May 2026